Table 3.
Summary of HPLC and SERS* Analysis Results for Patient Samples, reprinted with permission from ref. [45].
| concentration of mitoxantrone (ng/mL) | ||
|---|---|---|
| Time | HPLC | SERS * |
| 0 | 0 | nd |
| 5 | 3.1 | 2.9 |
| 10 | 1.9 | 1.0 |
| 15 | 252.3 | 247.3 |
| 20 | 186.9 | 183.2 |
| 30 | 53.7 | 54.1 |
| 45 | 23.7 | 20.3 |
| 60 | 11.6 | 9.2 |
| 90 | 9.4 | 8.9 |
| 120 | 6.2 | 6.0 |
| 180 | 5.7 | 4.8 |
| 240 | 1.8 | 1.0 |
| 360 | 3.2 | 3.0 |
| 720 | 1.8 | 1.3 |
* In this study, authors chose a laser frequency which is in resonance with the analyte, so they correctly defined it as surface enhanced resonance Raman spectroscopy (SERRS) instead of SERS.